<?xml version="1.0" ?>
<document id="45b4b6a49cc3373b0f67b014910073336dbca667">
  <chunk id="45b4b6a49cc3373b0f67b014910073336dbca667.c0" text="RNase L restricts the mobility of engineered retrotransposons in cultured human cells"/>
  <chunk id="45b4b6a49cc3373b0f67b014910073336dbca667.c1" text="Retrotransposons are mobile genetic elements, and their mobility can lead to genomic instability. Retrotransposon insertions are associated with a diverse range of sporadic diseases, including cancer. Thus, it is not a surprise that multiple host defense mechanisms suppress retrotransposition. The 2 0 ,5 0 -oligoadenylate (2-5A) synthetase (OAS)-RNase L system is a mechanism for restricting viral infections during the interferon antiviral response. Here, we investigated a potential role for the OAS-RNase L system in the restriction of retrotransposons. Expression of wild type (WT) and a constitutively active form of RNase L (N&quot;385), but not a catalytically inactive RNase L mutant (R667A), impaired the mobility of engineered human LINE-1 (L1) and mouse intracisternal A-type particle retrotransposons in cultured human cells. Furthermore, WT RNase L, but not an inactive RNase L mutant (R667A), reduced L1 RNA levels and subsequent expression of the L1-encoded proteins (ORF1p and ORF2p). Consistently, confocal immunofluorescent microscopy demonstrated that WT RNase L, but not RNase L R667A, prevented formation of L1 cytoplasmic foci. Finally, siRNA-mediated depletion of endogenous RNase L in a human ovarian cancer cell line (Hey1b) increased the levels of L1 retrotransposition by $2-fold. Together, these data suggest that RNase L might function as a suppressor of structurally distinct retrotransposons.">
    <entity charOffset="164-172" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e0" ontology_id="HP_0003745" text="sporadic" type="phenotype"/>
    <entity charOffset="193-199" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e1" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="275-293" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e2" ontology_id="GO_0032197" text="retrotransposition" type="gene_function"/>
    <entity charOffset="1222-1228" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e3" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1274-1292" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e4" ontology_id="GO_0032197" text="retrotransposition" type="gene_function"/>
    <pair e1="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e0" e2="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e2" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.p0" relation="true"/>
    <pair e1="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e0" e2="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e4" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.p1" relation="true"/>
    <pair e1="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e1" e2="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e2" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.p2" relation="true"/>
    <pair e1="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e1" e2="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e4" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.p3" relation="true"/>
    <pair e1="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e2" e2="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e3" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.p4" relation="true"/>
    <pair e1="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e3" e2="45b4b6a49cc3373b0f67b014910073336dbca667.c1.e4" id="45b4b6a49cc3373b0f67b014910073336dbca667.c1.p5" relation="true"/>
  </chunk>
</document>
